Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248
Clinical trial NCT04036227 · COMPLETED
Trial details
- NCT number
- NCT04036227
- Sponsor
- Gesynta Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2019-12-20
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.